ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy combo shows promise for advanced liver cancer
Disease control OngoingThis study tests a combination of two immunotherapy drugs (durvalumab and tremelimumab) as the first treatment for people with advanced liver cancer that cannot be removed by surgery. About 111 participants will receive the drugs to see how safe they are and whether they shrink t…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
New RNA combo shows promise in early liver cancer trial
Disease control OngoingThis early-phase study tests a new RNA-based drug (MTL-CEBPA) together with two immunotherapy drugs (atezolizumab and bevacizumab) in people with advanced liver cancer who have not had prior treatment. The goal is to find the safest dose and see how well the combination shrinks t…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Engineered immune cells take on tough liver cancer in early trial
Disease control TerminatedThis early-phase study tests a new treatment for adults with advanced liver cancer that has not responded to at least two standard therapies. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer cells that have a specific p…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Experimental cell infusion targets tough liver tumors
Disease control OngoingThis early-phase study tests a new cell therapy called CT0180 in 21 adults with advanced liver cancer that has not responded to other treatments. The main goals are to check safety, find the best dose, and see how the body handles the cells. Participants receive one or more infus…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New combo therapy shows promise for HIV patients with advanced cancer
Disease control OngoingThis early-phase trial is testing the safety of combining two cancer drugs—nivolumab and cabozantinib—in people with HIV who have advanced solid tumors. The study includes 8 participants with various cancers that have spread. The goal is to see if the combination can shrink or st…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC